Baystreet.ca – Psychedelics Could Alter a Potential $2.5 Trillion Mental Health Market

MINDCURE launched the Desire Project, a clinical research program studying MDMA-assisted psychotherapy for the treatment of HSDD in women. This is the first psychedelic-based program treating HSDD, a disorder that causes significant distress unattributable to other issues for the 10% of adult women it affects. In fact, it affects ~9.5 million premenopausal women in the US alone.